News

This is Ask An Expert, where every weekday at 9:20am, KCBS Radio is giving you direct access to top experts in various fields. Today: Gene-editing technology allows scientists to work with DNA in unprecedented ways, but there are larger scientific...

For months, a small company in San Francisco has been pursuing a secretive project: the birth of a genetically engineered baby.

Backed by OpenAI chief executive Sam Altman and his husband, along with Coinbase co-founder and CEO Brian Armstrong, the startup—called...

Pronatalism is an old idea with roots in eugenics and nationalism, that is now fashionable among far-right influencers and policymakers. They talk...

This is the 10th installment in the Legacies of Eugenics series, which features essays by leading thinkers devoted to exploring...

By Stephanie Nebehay, Reuters | 07.15.2016

GENEVA A U.N. human rights watchdog called on Kuwait on Friday to amend a counter-terrorism law requiring nationwide compulsory DNA...

By David Jester, Atlas Obscura | 07.14.2016

The cold green waters of the Gulf of Maine lap against the shore of Malaga Island. Lobster traps are stacked...

By Lisa Krieger, San Jose Mercury | 07.14.2016

STANFORD -- Some day -- when your heart needs healing, your bones need bonding or your skin needs stitching --...

By Jennifer K. Wagner, Genomics Law Report | 07.14.2016

On May 17, 2016, the Equal Employment Opportunity Commission (EEOC), which is the agency charged with enforcing Title II of...

By Nidhi Subbaraman, BuzzFeed | 07.14.2016

Gene editing must never be used to create “designer babies” with enhanced abilities, the director of the National Institutes of...

By Gina Kolata, The New York Times | 07.14.2016

Something strange is going on in medicine. Major diseases, like colon cancer, dementia and heart disease, are waning in...

By Editorial, The Korea Times | 07.13.2016

Embryonic stem cell research will resume soon after the Ministry of Health and Welfare granted conditional approval to a private...

By David Jensen, California Stem Cell Report | 07.13.2016

The California stem cell agency is set to award nearly $10 million for a phase 3 clinical trial to produce...